about
Etiology of cardiovascular disease in patients with schizophrenia: current perspectivesIllness perception of dropout patients followed up at bipolar outpatient clinic, Turkey.A case report of priapism caused by ziprasidon.Electroconvulsive Therapy and Oxidative Stress: Comment on the Article of Şenyurt et al. (Clin Psychophacol Neurosci 2017;15:40-46).Psychosis in a female patient with tuberous sclerosis.Atherogenic index of plasma as a cardiovascular risk marker in manic, depressive, and euthymic stages of bipolar disorder.Serum osmolarity in male patients with bipolar disorder manic episode.Comment on "Diabetes mellitus and first episode mania associated with cardiovascular diseases in patients with older-age bipolar disorder".Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment.Neutrophil and platelet to lymphocyte ratios in people with subjective, mild cognitive impairment and early Alzheimer's disease.Paliperidone and paliperidone-palmitat induced leukocytoclastic vasculitis.Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment.Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder.Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.Does Blood Flow Change according to Mood? Blood Rheology in Bipolar DisorderThe nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatmentDecreased circulating urokinase plasminogen activator receptor (uPAR) concentration in acute episodes of bipolar disorder; could it be a reflection of axonal injury?Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorderComparison of the complete blood count-derived inflammatory markers in bipolar patients with manic and mixed episodesSerum osmolarity and blood viscosity as a potential explanation for the pathophysiology of neuroleptic malignant syndromeA new interpretation of neutrophil-lymphocyte ratio from psychiatric aspectClinical utility of neutrophil-lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome
P50
Q26778485-F57B4791-59C7-4BD1-A6C7-7A04E7756AA3Q41002118-4556729F-8D8A-4905-A2C9-9B7CB5DED799Q41891436-EDDB3285-963E-4635-85F7-435DBDDB4AE4Q42348172-83092135-9477-4B14-AA95-D1243C2C48D8Q45750036-4E593CF6-8DCA-4C94-B343-ABED5635392AQ47555169-A12B357B-F4C1-4E69-A0B6-659C32AC9A3BQ47649686-240F22FF-01EF-482F-86B6-FDF30018462CQ47735164-C66E435C-C998-4D7B-A40A-74613F080517Q47749728-54ACC58E-0CC6-4893-9A4F-38B0AF06BBFAQ47754524-6EE3F294-98B3-42A5-BA04-BD99ED04DBDDQ47952648-3B1CE723-F45E-4D87-9C22-A6894A390216Q48195612-243A6FC8-1463-4B34-AF65-067C37767357Q48253261-7E7DCE14-6017-4992-B623-34EC55526F7FQ50545910-5F37B521-B182-4653-886E-4D248E6BCE99Q50579715-0FBFC92A-7118-4979-AE02-50934AB962FBQ50646805-25691DB3-0BF9-4069-9BD7-C1E64302F6A4Q58781431-16D1C9B4-0D75-4FFA-A2AE-EDF7E0B32064Q85987011-6231CDD1-7133-46E5-B39F-C98A9EF57ED4Q87884495-885137FC-3C44-40FA-8DA8-649CACEC33DAQ90421952-2140721F-819C-4629-937B-2D31B691667EQ91516368-2DA1BAE7-0287-46E8-96C9-BCEC2CA81143Q92215327-4A0DAB41-36D6-46D1-9600-60A77FFA2C3BQ92400356-E354E10C-A4FF-43B1-8329-A5716DC0C381Q92521340-59D193AB-3876-46CB-985A-A6E45C6EA936
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tevfik Kalelioglu
@ast
Tevfik Kalelioglu
@en
Tevfik Kalelioglu
@es
Tevfik Kalelioglu
@nl
Tevfik Kalelioglu
@sl
type
label
Tevfik Kalelioglu
@ast
Tevfik Kalelioglu
@en
Tevfik Kalelioglu
@es
Tevfik Kalelioglu
@nl
Tevfik Kalelioglu
@sl
prefLabel
Tevfik Kalelioglu
@ast
Tevfik Kalelioglu
@en
Tevfik Kalelioglu
@es
Tevfik Kalelioglu
@nl
Tevfik Kalelioglu
@sl
P106
P21
P31
P496
0000-0001-9319-055X
P569
2000-01-01T00:00:00Z